Cargando…

Myelin repair in Alzheimer’s disease: a review of biological pathways and potential therapeutics

This literature review investigates the significant overlap between myelin-repair signaling pathways and pathways known to contribute to hallmark pathologies of Alzheimer’s disease (AD). We discuss previously investigated therapeutic targets of amyloid, tau, and ApoE, as well as other potential ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirschfeld, Lauren Rose, Risacher, Shannon L., Nho, Kwangsik, Saykin, Andrew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598036/
https://www.ncbi.nlm.nih.gov/pubmed/36284351
http://dx.doi.org/10.1186/s40035-022-00321-1
_version_ 1784816232514453504
author Hirschfeld, Lauren Rose
Risacher, Shannon L.
Nho, Kwangsik
Saykin, Andrew J.
author_facet Hirschfeld, Lauren Rose
Risacher, Shannon L.
Nho, Kwangsik
Saykin, Andrew J.
author_sort Hirschfeld, Lauren Rose
collection PubMed
description This literature review investigates the significant overlap between myelin-repair signaling pathways and pathways known to contribute to hallmark pathologies of Alzheimer’s disease (AD). We discuss previously investigated therapeutic targets of amyloid, tau, and ApoE, as well as other potential therapeutic targets that have been empirically shown to contribute to both remyelination and progression of AD. Current evidence shows that there are multiple AD-relevant pathways which overlap significantly with remyelination and myelin repair through the encouragement of oligodendrocyte proliferation, maturation, and myelin production. There is a present need for a single, cohesive model of myelin homeostasis in AD. While determining a causative pathway is beyond the scope of this review, it may be possible to investigate the pathological overlap of myelin repair and AD through therapeutic approaches.
format Online
Article
Text
id pubmed-9598036
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-95980362022-10-27 Myelin repair in Alzheimer’s disease: a review of biological pathways and potential therapeutics Hirschfeld, Lauren Rose Risacher, Shannon L. Nho, Kwangsik Saykin, Andrew J. Transl Neurodegener Review This literature review investigates the significant overlap between myelin-repair signaling pathways and pathways known to contribute to hallmark pathologies of Alzheimer’s disease (AD). We discuss previously investigated therapeutic targets of amyloid, tau, and ApoE, as well as other potential therapeutic targets that have been empirically shown to contribute to both remyelination and progression of AD. Current evidence shows that there are multiple AD-relevant pathways which overlap significantly with remyelination and myelin repair through the encouragement of oligodendrocyte proliferation, maturation, and myelin production. There is a present need for a single, cohesive model of myelin homeostasis in AD. While determining a causative pathway is beyond the scope of this review, it may be possible to investigate the pathological overlap of myelin repair and AD through therapeutic approaches. BioMed Central 2022-10-26 /pmc/articles/PMC9598036/ /pubmed/36284351 http://dx.doi.org/10.1186/s40035-022-00321-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Hirschfeld, Lauren Rose
Risacher, Shannon L.
Nho, Kwangsik
Saykin, Andrew J.
Myelin repair in Alzheimer’s disease: a review of biological pathways and potential therapeutics
title Myelin repair in Alzheimer’s disease: a review of biological pathways and potential therapeutics
title_full Myelin repair in Alzheimer’s disease: a review of biological pathways and potential therapeutics
title_fullStr Myelin repair in Alzheimer’s disease: a review of biological pathways and potential therapeutics
title_full_unstemmed Myelin repair in Alzheimer’s disease: a review of biological pathways and potential therapeutics
title_short Myelin repair in Alzheimer’s disease: a review of biological pathways and potential therapeutics
title_sort myelin repair in alzheimer’s disease: a review of biological pathways and potential therapeutics
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598036/
https://www.ncbi.nlm.nih.gov/pubmed/36284351
http://dx.doi.org/10.1186/s40035-022-00321-1
work_keys_str_mv AT hirschfeldlaurenrose myelinrepairinalzheimersdiseaseareviewofbiologicalpathwaysandpotentialtherapeutics
AT risachershannonl myelinrepairinalzheimersdiseaseareviewofbiologicalpathwaysandpotentialtherapeutics
AT nhokwangsik myelinrepairinalzheimersdiseaseareviewofbiologicalpathwaysandpotentialtherapeutics
AT saykinandrewj myelinrepairinalzheimersdiseaseareviewofbiologicalpathwaysandpotentialtherapeutics